Post-progression survival in patients with non-small cell lung cancer with clinically acquired resistance to gefitinib. [electronic resource]
Producer: 20140714Description: 1595-602 p. digitalISSN:- 1598-6357
- Adenocarcinoma -- drug therapy
- Adenocarcinoma of Lung
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Disease-Free Survival
- Drug Resistance, Neoplasm
- Female
- Gefitinib
- Glutamates -- therapeutic use
- Guanine -- analogs & derivatives
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Pemetrexed
- Protein Kinase Inhibitors -- therapeutic use
- Quinazolines -- therapeutic use
- Retrospective Studies
- Survival
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.